Why We're Different
More than just a CRO, at Tergus we work with your development team as an extension of your own laboratory. In doing so, we leverage our core strength: our team’s technical leadership in topicals. Our unparalleled expertise ranges from Concept to Commercialization.
We pioneered Quality by Design (QbD) for topical development and are experts at risk-based approaches, strategic planning and innovative drug product design. We can help your company avoid unnecessary costs and delays through manufacturing and commercialization.
Using years of developmental experience, combined with understanding the best path forward for clinical and regulatory affairs, we are the single destination to reach topical product development goals.
Globally recognized expertise
Founders Dr. Kailas Thakker and Dr. Vijendra Nalamothu are globally recognized experts in the field of dermatology drug development and analysis. Dr. Thakker has been speaking globally on the topic of in vitro release (Franz diffusion) method development, validation and testing including workshops on theory and application. These workshops have been conducted in Brazil, Japan, and Korea and are scheduled in additional global locations in the coming year.
Regulatory Scope of Services
Dr. Nalamothu has worked for years with early stage compounds evaluating feasibility for topical drug products. He has extensive experience moving programs from development through clinical trials, through early and late stage regulatory, and through scale up and commercial site manufacturing.
Focus on Topicals
The primary focus of Tergus Pharma is semi-solid product development, formulation, analysis, testing, cGMP clinical supply manufacturing.
We develop novel formulations and platform technologies providing clients with a competitive edge.
Intellectual Property Generation
Tergus Pharma can work to develop intellectual property exclusively for the use of clients, providing a superior market position.
Tergus can handle multiple projects of formulation development, IVRT, scale -up & tech transfer activities.